Atlas Trials

Glial Tumors Electromagnetic Signature Study by MagnetoEncephaloGraphy (MEG) "CONDUCTOME"

Clinical trial NCT02077504 · TERMINATED

Trial details

NCT number
NCT02077504
Sponsor
University Hospital, Grenoble
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Cerebral Primitive Tumor With Chirurgical Indication
Start date
2013-09-01
Primary completion
2018-01-05
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.